Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
Aim. To describe best practices in using human normal immunoglobulin in patients with immune-mediated neurological disorders according to the data of one clinical center.Materials and methods. From 2016 to 2021, 20 patients with various autoimmune disorders of the peripheral and central nervous syst...
Saved in:
Main Authors: | N. M. Tereshchenko, Ya. B. Kushnir, M. P. Abramova, A. A. Gotovchikov, V. S. Krasnov, A. Y. Sokolov, N. A. Totolyan, A. V. Amelin |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2023-04-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/5142 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous high-dose immunotherapy: practical recommendations for use in the treatment of neurological disimmune diseases
by: N. A. Suponeva, et al.
Published: (2015-12-01) -
Immunoglobulins in neurological practice: a review of the literature
by: S. S. Nikitin, et al.
Published: (2019-04-01) -
Experience of using Rituximab in neurological practice (literature review and own observation)
by: Ya. B. Kushnir, et al.
Published: (2021-11-01) -
Conduction block as an electrophysiological phenomenon: a review of the literature
by: S. S. Nikitin, et al.
Published: (2019-04-01) -
Guillain-Barre Syndrome in A Patient with Infectious Endocarditis: Clinical Observation and Literature Review
by: E. V. Reznik, et al.
Published: (2025-07-01)